Bivin & Associates, Inc. Alector, Inc. Transaction History
Bivin & Associates, Inc.
- $93.1 Million
- Q2 2022
Shares
2 transactions
Others Institutions Holding ALEC
# of Institutions
144Shares Held
54.6MCall Options Held
29.8KPut Options Held
13.4K-
Black Rock Inc. New York, NY9.1MShares$30.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.99MShares$19.8 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.88MShares$16.1 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA2.17MShares$7.18 Million0.01% of portfolio
-
Eversept Partners, LP New York, NY1.99MShares$6.57 Million0.28% of portfolio
About Alector, Inc.
- Ticker ALEC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,563,904
- Market Cap $273M
- Description
- Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...